Navigation Links
Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens
Date:12/23/2009

WINNIPEG, Manitoba, Dec. 23 /PRNewswire/ -- In the midst of President Obama's push for health care reform, the Senate rejected a plan to allow American pharmacies and drug wholesalers to import federally approved drugs from abroad. That vote has proved to be a headache for customer service staff at companies like Canadameds.com (http://www.Canadameds.com), which sells low-cost prescription drugs directly to American consumers.

"Our call center has received many calls from Canadameds.com customers," said call center manager Richmon Sagun. "Consumers are afraid the Senate vote means they will no longer be able to order from Canadameds.com. Callers have been worried that this vote has put Canadameds out of business but that, of course, is not the case. The vote only prohibits mass importation - wholesale orders - not personal importation. So it's business as usual for us."

Prescription drug prices have more than doubled in the last five years, and in the U.S., where drugs cost more than anywhere else in the world, more than one-third of senior citizens have inadequate prescription drug coverage. Consequently, Sagun explained, U.S. seniors flock to companies like Canadameds.com. "Our Canada pharmacy is here to help. We fill every online prescription submitted to our Canadian pharmacy completely and at a fair price," stated Sagun. "We even go beyond the borders of Canada to obtain the best-quality prescription drugs for our patients. Customers save up to 70 percent on Canadian and global affiliate drugs, with the assurance that we meet - and often surpass - U.S. safety standards."

For example, a Canadameds.com search for Celebrex shows both name-brand and generic options and provides the cost comparison of the drug sourced from four different countries. A prescription of 100 x 200-mg capsules of brand-name Celebrex from Canada costs 60 percent less than the same prescription from the U.S. The generic equivalent from India offers even greater savings at 76 percent less per capsule than the U.S. brand-name offering.

Canadameds.com is committed to patients' rights to access safe, affordable, prescription drugs. Its efforts include lobbying to support the "Preserving Access to Safe, Affordable Canadian Medicines Act of 2003," a House bill designed to help ensure that Canadian prescription medications are available to seniors.

For more information, visit http://www.canadameds.com or call toll-free at 1-877-542-3330.

About Canadameds.com

Canadameds.com's mission is to provide the finest Canadian drugs and pharmacy services in a safe, efficient manner. Because Canadameds is a drug dispenser based in Canada, where the government negotiates with the pharmaceutical industry to keep prices affordable for consumers, Canadameds products cost up to 70% less than identical products in the U.S. An industry leader in mail-order prescription services, Canadameds holds a pharmaceutical license and is staffed by qualified pharmacists and pharmacy technicians.


    Contact:

    Richmon Sagun
    Canadameds.com
    1-877-542-3330
    pharmacist@Canadameds.com
    http://www.Canadameds.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Canadameds.com


'/>"/>
SOURCE Canadameds.com
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Physician Groups Oppose Current Senate Health Care Reform Bill
2. RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgans Drug Importation Plan Puts Seniors at Risk
3. PhRMA Statement on Senate Finance Committee Vote
4. AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform
5. Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases
6. Senate Told Brain Technology Can Impact Public Policy
7. Federal Judge Rejects GlaxoSmithKlines Claims of Privilege
8. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
9. China Medicine Announces Changes to Management Team
10. Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World
11. Results From Phase II Trial in Critical Care Medicine Showed Eritoran Tetrasodium (E5564) To Be Well Tolerated in Patients with Severe Sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ALEX , has taken Kickstarter by storm, crowdfunding over $60,000 – or 120% of its original ... to be delivered to backers starting May of this year. ... ... ... Created by NAMU, a team of biomedical engineers out of ...
(Date:2/11/2016)... ROLLING MEADOWS , Ill. and INDIANAPOLIS ... major milestone for many young people, but for those ... demanding. Not only do these students juggle class schedules, ... challenges of living with type 1 diabetes. On top ... the first time. Diabetes Scholars Foundation ...
(Date:2/11/2016)... Feb. 11, 2016  AbbVie, a global biopharmaceutical ... Scholarship, designed to provide financial support for exceptional ... pursue higher education goals. Fifteen scholars will be ... school year. The AbbVie Rheumatology Scholarship is currently ... vice president, corporate social responsibility, brand and communications, ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 12, 2016 , ... The Journal ... up from 0.416 in 2013. The SJR uses data taken from the Scopus database ... both the number of citations received by the journal over a three year period ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health and ... for their simultaneous grand openings in March. All seven practices are set to ... wondering, is reversing diabetes possible? According to this 2011 CNN article it is ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans and ... health care system that’s partnering with Intel on value-based health benefits program Connected ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... Long Island, NY (PRWEB) , ... February 11, ... ... (INS) has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, ... global leader in vein illumination with an estimated 85% share of the market, ...
Breaking Medicine News(10 mins):